David Meeker is Chairman of the Board, President and Chief Executive Officer of Rhythm Pharmaceuticals, Inc. (RYTM). The company reported total compensation of $17,544,525 for fiscal year 2025.
| Salary | $807,692 |
|---|---|
| Bonus | $0 |
| Stock awards | $8,274,785 |
| Option awards | $7,688,560 |
| Non-equity incentive plan | $759,488 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $14,000 |
| Total | $17,544,525 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Rhythm Pharmaceuticals, Inc. filed April 29, 2026, accession 0001628280-26-028375.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chairman of the Board, President and Chief Executive Officer | $807,692 | $0 | $8,274,785 | $7,688,560 | $759,488 | $0 | $14,000 | $17,544,525 |
| FY2024 | Chief Executive Officer | $740,472 | — | $4,382,955 | $8,784,115 | $744,135 | — | $12,065 | $14,663,742 |
| FY2023 | Chief Executive Officer | $704,715 | — | $1,545,275 | $4,334,521 | $634,053 | — | $11,893 | $7,230,457 |
Totals as disclosed in each year's own compensation disclosure for Rhythm Pharmaceuticals, Inc..
| Peer-group chief executive median | $11,056,910 |
|---|---|
| Difference from that median | $6,487,616 |
| Percentile within the disclosed peer group | 85th |
| Peers with a disclosed figure | 19 |
Medians and percentiles are computed across the peer group Rhythm Pharmaceuticals, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| David Meeker this page | Chairman of the Board, President and Chief Executive Officer | $17,544,525 |
| Hunter Smith | Chief Financial Officer and Treasurer | $6,228,429 |
| Yann Mazabraud | Executive Vice President, Head of International | $6,118,455 |
| Jennifer Lee | Executive Vice President, Head of North America | $5,602,816 |
| Alastair Garfield | Chief Scientific Officer | $4,427,024 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Rhythm Pharmaceuticals, Inc. compensation brief.
David Meeker's compensation sits inside Rhythm Pharmaceuticals, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.